Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster systematic - analysis

Terms

114systematic
145analysis
69meta
121safety
82efficacy
59cohort
50retrospective
51observational

Associations

Freq.WeightAssociation
6666analysis - meta
5757meta - systematic
5555analysis - systematic
4444efficacy - safety
2323safety - systematic
2222analysis - safety
2121meta - safety
1919efficacy - systematic
1616analysis - efficacy
1515efficacy - meta
1313analysis - retrospective
1717cohort - retrospective
1111cohort - observational

Documents par ordre de pertinence
000089 (2021) Kimberley Lewis [Canada] ; Dipayan Chaudhuri [Canada] ; Fayez Alshamsi [Émirats arabes unis] ; Laiya Carayannopoulos [Canada] ; Karin Dearness [Canada] ; Zain Chagla [Canada] ; Waleed Alhazzani [Canada]The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.
000090 (2021) Anirban Hom Choudhuri [Inde] ; Sakshi Duggal [Inde] ; Bhuvna Ahuja [Inde] ; Partha Sarathi Biswas [Inde]The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
000522 (2021) Jogender Kumar [Inde] ; Siddharth Jain [Inde] ; Jitendra Meena [Inde] ; Arushi Yadav [Inde]Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
000523 (2021) Paul Eze [États-Unis] ; Kenechukwu N. Mezue [États-Unis] ; Chidozie U. Nduka [Royaume-Uni] ; Ijeoma Obianyo [Nigeria] ; Obiora Egbuche [États-Unis]Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
000865 (2020) Anusuya Bhattacharyya [Inde] ; Subodh Kumar [Inde] ; Phulen Sarma [Inde] ; Hardeep Kaur [Inde] ; Manisha Prajapat [Inde] ; Nishant Shekhar [Inde] ; Seema Bansal [Inde] ; Pramod Avti [Inde] ; Mythili Hazarika [Inde] ; Saurabh Sharma [Inde] ; Dhruv Mahendru [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde]Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis.
000C44 (2020) Waqas Ullah [États-Unis] ; Hafez M Abdullah [États-Unis] ; Sohaib Roomi [États-Unis] ; Yasar Sattar [États-Unis] ; Talal Almas [Irlande (pays)] ; Smitha Narayana Gowda [États-Unis] ; Rehan Saeed [États-Unis] ; Maryam Mukhtar [Pakistan] ; Ammar Ahmad [Pakistan] ; Tony Oliver [États-Unis] ; M Chadi Alraies [États-Unis] ; Donald C. Haas [États-Unis] ; David L. Fischman [États-Unis]Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
001323 (2020) Nang S. Choupoo [Inde] ; Saurabh K. Das [Inde] ; Rudrashish Haldar [Inde] ; Hillol Sarkar [Inde] ; Resma Tewari [Inde] ; Sumit Ray [Inde]Evaluating the Efficacy and Safety of the Existing Repurposed Pharmacological Agents for Treating COVID-19: A Meta-analysis and Systematic Review of Clinical Trials.
001353 (2020) Han Zhong [République populaire de Chine] ; Yan Wang [République populaire de Chine] ; Zai-Li Zhang [République populaire de Chine] ; Yang-Xi Liu [République populaire de Chine] ; Ke-Jia Le [République populaire de Chine] ; Min Cui [République populaire de Chine] ; Yue-Tian Yu [République populaire de Chine] ; Zhi-Chun Gu [République populaire de Chine] ; Yuan Gao [République populaire de Chine] ; Hou-Wen Lin [République populaire de Chine]Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.
001354 (2020) Yan Liu [République populaire de Chine] ; Xiaoxu Fu ; Chunguang XieEfficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
001356 (2020) Wei Liu [République populaire de Chine] ; Pengxiang Zhou [République populaire de Chine] ; Ken Chen [République populaire de Chine] ; Zhikang Ye [République populaire de Chine] ; Fang Liu [République populaire de Chine] ; Xiaotong Li [République populaire de Chine] ; Na He [République populaire de Chine] ; Ziyang Wu [République populaire de Chine] ; Qi Zhang [République populaire de Chine] ; Xuepeng Gong [République populaire de Chine] ; Qiyu Tang [République populaire de Chine] ; Xin Du [République populaire de Chine] ; Yingqiu Ying [République populaire de Chine] ; Xiaohan Xu [République populaire de Chine] ; Yahui Zhang [République populaire de Chine] ; Jinyu Liu [République populaire de Chine] ; Yun Li [République populaire de Chine] ; Ning Shen [République populaire de Chine] ; Rachel J. Couban [République populaire de Chine] ; Quazi I. Ibrahim [République populaire de Chine] ; Gordon Guyatt [République populaire de Chine] ; Suodi Zhai [Oman]Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.
001357 (2020) Rashmi Ranjan Das [Inde] ; Nishant Jaiswal [Inde] ; Nishanth Dev [Inde] ; Nikita Jaiswal [Inde] ; Sushree Samiksha Naik [Inde] ; Jhuma Sankar [Inde]Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis.
001535 (2020) Min Seo Kim [Corée du Sud] ; Min Ho An [Corée du Sud] ; Won Jun Kim [Corée du Sud] ; Tae-Ho Hwang [Corée du Sud]Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
000080 (2021) Rong Qiu ; Jingwei Li ; Yuxuan Xiao ; Ziyi Gao ; Yihang Weng ; Qiran Zhang ; Chengdi Wang ; Hanlin Gong [République populaire de Chine] ; Weimin LiThe therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis.
000106 (2021) Abdulkarim Abdulrahman [Bahreïn] ; Islam Alsayed [Bahreïn] ; Marwa Almadhi [Royaume-Uni] ; Jumana Alarayed [Bahreïn] ; Sara Jaafar Mohammed [Bahreïn] ; Aesha Khalid Sharif [Bahreïn] ; Khadija Alansari [Bahreïn] ; Abdulla Ismael Alawadhi [Bahreïn] ; Manaf Alqahtani [Bahreïn]The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort.
000113 (2021) Tzu-Han Yang [République populaire de Chine] ; Chian-Ying Chou [République populaire de Chine] ; Yi-Fan Yang [République populaire de Chine] ; Chian-Shiu Chien [République populaire de Chine] ; Aliaksandr A. Yarmishyn [République populaire de Chine] ; Tzu-Ying Yang [République populaire de Chine] ; Cheng-Hsuan Liu [République populaire de Chine] ; Kao-Jung Chang [République populaire de Chine] ; Yi-Ping Yang [République populaire de Chine] ; Yuh-Lih Chang [République populaire de Chine]Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients.
000151 (2021) Fernando Luiz Barros Edington [Brésil] ; Sandra Rocha Gadellha [Brésil] ; Mittermayer Barreto Santiago [Brésil]Safety of treatment with chloroquine and hydroxychloroquine: A ten-year systematic review and meta-analysis.
000154 (2021) Can Chen [République populaire de Chine] ; Kunming Pan [République populaire de Chine] ; Bingjie Wu [République populaire de Chine] ; Xiaoye Li [République populaire de Chine] ; Zhangzhang Chen [République populaire de Chine] ; Qing Xu [République populaire de Chine] ; Xiaoyu Li [République populaire de Chine] ; Qianzhou Lv [République populaire de Chine]Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.
000155 (2021) Alberto Enrico Maraolo [Italie] ; Adriano Grossi [Italie]Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials.
000519 (2021) Zakariya Kashour [Canada] ; Muhammad Riaz [Pakistan] ; Musa A. Garbati [Nigeria] ; Oweida Aldosary [Arabie saoudite] ; Haytham Tlayjeh [Arabie saoudite] ; Dana Gerberi [États-Unis] ; M Hassan Murad [États-Unis] ; M Rizwan Sohail [États-Unis] ; Tarek Kashour [Arabie saoudite] ; Imad M. Tleyjeh [Arabie saoudite, États-Unis]Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
001348 (2020) Shubham Misra [Inde] ; Manabesh Nath [Inde] ; Vijay Hadda [Inde] ; Deepti Vibha [Inde]Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis.
001870 (2020) Lu Ren ; Wilson Xu ; James L. Overton ; Shandong Yu [République populaire de Chine] ; Nipavan Chiamvimonvat ; Phung N. ThaiAssessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
001871 (2020) Lu Ren [États-Unis] ; Wilson Xu [États-Unis] ; James L. Overton [États-Unis] ; Shandong Yu [République populaire de Chine] ; Nipavan Chiamvimonvat [États-Unis] ; Phung N. Thai [États-Unis]Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
000012 (2021) Sourabh Agstam [Inde] ; Ashutosh Yadav [Inde] ; Praveen Kumar-M [Inde] ; Ankur Gupta [Inde]Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis.
000015 (2021) Roberto Ariel Abelda O Zu Iga [Mexique] ; Silvia Mercedes Coca [Mexique] ; Giuliana Florencia Abelda O [Mexique] ; Ruth Ana María González-Villoria [Mexique]Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis.
000020 (2021) Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie][The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000114 (2021) Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis]Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
000157 (2021) Ozgur Sogut [Turquie] ; Mehmet Mustafa Can [Turquie] ; Ramazan Guven [Turquie] ; Onur Kaplan [Turquie] ; Hüseyin Ergenc [Turquie] ; Tuba Betül Umit [Turquie] ; Olgun Demir [Turquie] ; Murat Kaya [Turquie] ; Tar K Akdemir [Turquie] ; Sümeyye Cakmak [Turquie]Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study.
000207 (2021) Manya Prasad [Inde] ; Arunmozhimaran Elavarasi [Inde] ; Pramod Garg [Inde]Reply to the Letter to Editor by Lacout and colleagues: Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
000234 (2021) Carlos Diaz-Arocutipa [Pérou] ; Ana Bra Ez-Condorena [Pérou] ; Adrian V. Hernandez [Pérou, États-Unis]QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
000245 (2021) Jessica J. Bartoszko [Canada] ; Reed A C. Siemieniuk [Canada] ; Elena Kum [Canada] ; Anila Qasim [Canada] ; Dena Zeraatkar [Canada] ; Long Ge [République populaire de Chine] ; Mi Ah Han [Corée du Sud] ; Behnam Sadeghirad [Canada] ; Arnav Agarwal [Canada] ; Thomas Agoritsas [Canada, Suisse] ; Derek K. Chu [Canada] ; Rachel Couban [Canada] ; Andrea J. Darzi [Canada] ; Tahira Devji [Canada] ; Maryam Ghadimi [Canada] ; Kimia Honarmand [Canada] ; Ariel Izcovich [Argentine] ; Assem Khamis [Royaume-Uni] ; Francois Lamontagne [Canada] ; Mark Loeb [Canada] ; Maura Marcucci [Canada] ; Shelley L. Mcleod [Canada] ; Sharhzad Motaghi [Canada] ; Srinivas Murthy [Canada] ; Reem A. Mustafa [États-Unis] ; John D. Neary [Canada] ; Hector Pardo-Hernandez [Espagne] ; Gabriel Rada [Chili] ; Bram Rochwerg [Canada] ; Charlotte Switzer [Canada] ; Britta Tendal [Australie] ; Lehana Thabane [Canada] ; Per O. Vandvik [Norvège] ; Robin W M. Vernooij [Pays-Bas] ; Andrés Viteri-García [Chili, Équateur] ; Ying Wang [Canada] ; Liang Yao [Canada] ; Zhikang Ye [Canada] ; Gordon H. Guyatt [Canada] ; Romina Brignardello-Petersen [Canada]Prophylaxis against covid-19: living systematic review and network meta-analysis.
000321 (2021) Zakariya Kashour [Canada] ; Tarek Kashour ; Danielle Gerberi [États-Unis] ; Imad M. Tleyjeh [Arabie saoudite, États-Unis]Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
000364 (2021) Pravash Budhathoki [Népal] ; Dhan Bahadur Shrestha [Népal] ; Sitaram Khadka [Népal] ; Era Rawal [Népal]Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.
000413 (2021) Yanxiang Zang [République populaire de Chine] ; Xuejie Han [République populaire de Chine] ; Meijiao He [République populaire de Chine] ; Jing Shi [République populaire de Chine] ; Yue Li [République populaire de Chine]Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis.
000437 (2021) Hozaifa Khalil Elsawah [Égypte] ; Mohamed Ahmed Elsokary [Égypte] ; Mahmoud Gamal Elrazzaz [Égypte] ; Ahmed Hanei Elshafie [Égypte]Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials.
000447 (2021) Risa Ebina-Shibuya [États-Unis] ; Ho Namkoong [États-Unis] ; Nobuyuki Horita [Japon] ; Hideaki Kato [Japon] ; Yu Hara [Japon] ; Nobuaki Kobayashi [Japon] ; Takeshi Kaneko [Japon]Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials.
000505 (2021) Zeinab Abdelrahman [République populaire de Chine] ; Qian Liu [République populaire de Chine] ; Shanmei Jiang [République populaire de Chine] ; Mengyuan Li [République populaire de Chine] ; Qingrong Sun [République populaire de Chine] ; Yue Zhang [République populaire de Chine] ; Xiaosheng Wang [République populaire de Chine]Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis.
000507 (2021) Meng Wang [République populaire de Chine] ; Ting Wu [République populaire de Chine] ; Zhihong Zuo [République populaire de Chine] ; Yaxian You [République populaire de Chine] ; Xinyuan Yang [République populaire de Chine] ; Liangyu Pan [République populaire de Chine] ; Ying Hu [République populaire de Chine] ; Xuan Luo [République populaire de Chine] ; Liping Jiang [République populaire de Chine] ; Zanxian Xia [République populaire de Chine] ; Meichun Deng [République populaire de Chine]Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.
000536 (2021) Thibault Fiolet [France] ; Anthony Guihur [Suisse] ; Mathieu Edouard Rebeaud [Suisse] ; Matthieu Mulot [Suisse] ; Nathan Peiffer-Smadja [France] ; Yahya Mahamat-Saleh [France]Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
000575 (2021) Pallavi Dubey [États-Unis] ; Bhaskar Thakur [États-Unis] ; Sireesha Reddy [États-Unis] ; Carla A. Martinez [États-Unis] ; Md Nurunnabi [États-Unis] ; Sharron L. Manuel [États-Unis] ; Sadhana Chheda [États-Unis] ; Christina Bracamontes [États-Unis] ; Alok K. Dwivedi [États-Unis]Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis.
000596 (2021) Franco De Crescenzo [Royaume-Uni, Italie] ; Laura Amato [Italie] ; Fabio Cruciani [Italie] ; Luke P. Moynihan [Royaume-Uni] ; Gian Loreto D'Al [Italie] ; Simona Vecchi [Italie] ; Rosella Saulle [Italie] ; Zuzana Mitrova [Italie] ; Valeria Di Franco [Italie] ; Antonio Addis [Italie] ; Marina Davoli [Italie]Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis.
000656 (2021) Imad M. Tleyjeh [Arabie saoudite, États-Unis] ; Zakariya Kashour [Canada] ; Oweida Aldosary [Arabie saoudite] ; Muhammad Riaz [Pakistan] ; Haytham Tlayjeh [Arabie saoudite] ; Musa A. Garbati [Nigeria] ; Rana Tleyjeh [Arabie saoudite] ; Mouaz H. Al-Mallah [États-Unis] ; M Rizwan Sohail [États-Unis] ; Dana Gerberi [États-Unis] ; Aref A. Bin Abdulhak [États-Unis] ; John R. Giudicessi [États-Unis] ; Michael J. Ackerman [États-Unis] ; Tarek Kashour [Arabie saoudite]Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis.
000683 (2021) Mohammed A. Raja [États-Unis] ; Maria A. Mendoza [États-Unis] ; Aasith Villavicencio [États-Unis] ; Shweta Anjan [États-Unis] ; John M. Reynolds [États-Unis] ; Veraprapas Kittipibul [États-Unis] ; Anmary Fernandez [États-Unis] ; Giselle Guerra [États-Unis] ; Jose F. Camargo [États-Unis] ; Jacques Simkins [États-Unis] ; Michele I. Morris [États-Unis] ; Lilian A. Abbo [États-Unis] ; Yoichiro Natori [États-Unis]COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.
000731 (2021) Michael Putman [États-Unis] ; Yu Pei Eugenia Chock [États-Unis] ; Herman Tam [Canada] ; Alfred H J. Kim [États-Unis] ; Sebastian E. Sattui [États-Unis] ; Francis Berenbaum [France] ; Maria I. Danila ; Peter Korsten [Allemagne] ; Catalina Sanchez-Alvarez [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Laura C. Coates [Royaume-Uni] ; Candace Palmerlee [États-Unis] ; Andrea Peirce [États-Unis] ; Arundathi Jayatilleke [États-Unis] ; Sindhu R. Johnson [Canada] ; Adam Kilian [États-Unis] ; Jean Liew [États-Unis] ; Larry J. Prokop [États-Unis] ; M Hassan Murad [États-Unis] ; Rebecca Grainger [Nouvelle-Zélande] ; Zachary S. Wallace [États-Unis] ; Alí Duarte-García [États-Unis]Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
000815 (2020) Aimé Bonny [Cameroun] ; Mohammed A. Talle [Nigeria] ; Marcus Ngantcha [Cameroun] ; Muzahir H. Tayebjee [Royaume-Uni]Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
000824 (2020) Dr Subodh Kumar Pathak [Inde] ; Dr Abhijeet Ashok Salunke [Inde] ; Dr Praveen Thivari [Inde] ; Apurva Pandey [Inde] ; Dr Kunal Nandy [Inde] ; Dr Harish V K Ratna [Inde] ; Dr Sanjay Pandey [Inde] ; Dr Jasneet Chawla [Inde] ; Dr Jalil Mujawar [Inde] ; Dr Anant Dhanwate [Inde] ; Dr Vivek Menon [Inde]No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials".
000878 (2020) Khalid Eljaaly [États-Unis] ; Kasim Huseein Alireza [Arabie saoudite] ; Samah Alshehri [États-Unis] ; Jaffar A. Al-Tawfiq [États-Unis]Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
000886 (2020) Awadhesh Kumar Singh [Inde] ; Akriti Singh [Inde] ; Ritu Singh [Inde] ; Anoop Misra [Inde]"Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis."
000988 (2020) Phulen Sarma [Inde] ; Hardeep Kaur [Inde] ; Harish Kumar [Inde] ; Dhruv Mahendru [Inde] ; Pramod Avti [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Nishant Shekhar [Inde] ; Subodh Kumar [Inde] ; Rahul Singh [Inde] ; Ashutosh Singh [Inde] ; Deba Prasad Dhibar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde]Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.
000A20 (2020) Andrea Cortegiani [Italie] ; Mariachiara Ippolito [Italie] ; Giulia Ingoglia [Italie] ; Pasquale Iozzo [Italie] ; Antonino Giarratano [Italie] ; Sharon Einav [Israël]Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.
000B23 (2020) Kuma Diriba [Éthiopie] ; Ephrem Awulachew [Éthiopie] ; Eyob Getu [Éthiopie]The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.
000B39 (2020) Amir Shamshirian [Iran] ; Amirhossein Hessami ; Keyvan Heydari ; Reza Alizadeh Navaei ; Mohammad Ali Ebrahimzadeh ; George W. Yip ; Roya Ghasemian ; Meghdad Sedaghat ; Hananeh Baradaran ; Soheil Mohammadi Yazdi ; Elham Aboufazeli ; Hamed Jafarpour ; Ehsan Dadgostar ; Behnaz Tirandazi ; Reza Sadeghnezhad ; Keyvan Karimifar ; Aida Eftekhari ; Danial ShamshirianThe Role of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
000B45 (2020) Teshale Ayele Mega [Éthiopie] ; Temesgen Mulugeta Feyissa [Éthiopie] ; Dula Dessalegn Bosho [Éthiopie] ; Kabaye Kumela Goro [Éthiopie] ; Getandale Zeleke Negera [Éthiopie]The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
000D36 (2020) Pinky Kotecha [Royaume-Uni] ; Alexander Light [Royaume-Uni] ; Enrico Checcucci [Italie] ; Daniele Amparore [Italie] ; Cristian Fiori [Italie] ; Francesco Porpiglia [Italie] ; Prokar Dasgupta [Royaume-Uni] ; Oussama Elhage [Royaume-Uni]Repurposing of drugs for Covid-19: a systematic review and meta-analysis.
000D65 (2020) Nicolas Vedrines [France] ; Anne-Typhaine Bouthors [France] ; Stéphane Gayet [France] ; Alexis Lacout [France]Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
000E39 (2020) Qianling Shi [République populaire de Chine] ; Qi Zhou [République populaire de Chine] ; Xia Wang [République populaire de Chine] ; Jing Liao [République populaire de Chine] ; Yang Yu [République populaire de Chine] ; Zijun Wang [République populaire de Chine] ; Shuya Lu [République populaire de Chine] ; Yanfang Ma [République populaire de Chine] ; Yangqin Xun [République populaire de Chine] ; Xufei Luo [République populaire de Chine] ; Weiguo Li [République populaire de Chine] ; Toshio Fukuoka [Japon] ; Hyeong Sik Ahn [Corée du Sud] ; Myeong Soo Lee [Corée du Sud] ; Zhengxiu Luo [République populaire de Chine] ; Enmei Liu [République populaire de Chine] ; Yaolong Chen [République populaire de Chine] ; Qubei Li [République populaire de Chine] ; Kehu Yang [République populaire de Chine] ; Quanlin Guan [République populaire de Chine]Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: a rapid review and meta-analysis.
001026 (2020) Haleh Talaie [Iran] ; Sayed Masoud Hosseini [Iran] ; Maryam Nazari [Iran] ; Yadollah Fakhri [Iran] ; Atieh Mousavizadeh [Iran] ; Hossein Vatanpour [Iran] ; Ali Firoozfar [Iran]Is there any potential management against COVID-19? A systematic review and meta-analysis.
001096 (2020) Thomas S. Hong [États-Unis] ; Jimmy Gonzalez [États-Unis] ; Ronald G. Nahass [États-Unis] ; Luigi Brunetti [États-Unis]Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis.
001362 (2020) Siddharth Shah [États-Unis] ; Kuldeep Shah ; Mohit K. Turagam ; Dhanunjaya Lakkireddy ; Jalaj GargEffects of Hydroxychloroquine With or Without Azithromycin on QT Interval in COVID-19: A Systematic Review. Electrophysiology Collaborative Consortium for Meta-analysis-Electram Investigators.
001394 (2020) Reed Ac Siemieniuk [Canada, République populaire de Chine] ; Jessica J. Bartoszko [Argentine, République populaire de Chine] ; Long Ge [Espagne, République populaire de Chine] ; Dena Zeraatkar [Argentine, République populaire de Chine] ; Ariel Izcovich [Espagne] ; Elena Kum [Argentine] ; Hector Pardo-Hernandez [Canada] ; Bram Rochwerg [Argentine, Corée du Sud] ; Francois Lamontagne [République populaire de Chine] ; Mi Ah Han [République populaire de Chine] ; Qin Liu [Canada, Suisse] ; Arnav Agarwal [Argentine, Canada] ; Thomas Agoritsas [Argentine, Canada] ; Derek K. Chu [Argentine, Corée du Sud] ; Rachel Couban [Norvège] ; Andrea Darzi [Argentine] ; Tahira Devji [Argentine] ; Bo Fang [Canada, Suisse] ; Carmen Fang [Norvège] ; Signe Agnes Flottorp [Canada] ; Farid Foroutan [Argentine, République populaire de Chine] ; Maryam Ghadimi [Canada] ; Diane Heels-Ansdell [Argentine] ; Kimia Honarmand [Espagne] ; Liangying Hou [Espagne] ; Xiaorong Hou [Canada] ; Quazi Ibrahim [Argentine] ; Assem Khamis [Canada] ; Bonnie Lam [Canada] ; Mark Loeb [Argentine, Corée du Sud] ; Maura Marcucci [Argentine, Corée du Sud] ; Shelley L. Mcleod [Canada, États-Unis] ; Sharhzad Motaghi [Argentine] ; Srinivas Murthy [Chili] ; Reem A. Mustafa [Argentine, Chili] ; John D. Neary [Espagne] ; Anila Qasim [Argentine] ; Gabriel Rada [États-Unis, Australie] ; Irbaz Bin Riaz [Canada] ; Behnam Sadeghirad [Argentine, Norvège] ; Nigar Sekercioglu [Argentine] ; Lulu Sheng [Canada, Suisse] ; Ashwini Sreekanta [Canada] ; Charlotte Switzer [Argentine] ; Britta Tendal [Pays-Bas] ; Lehana Thabane [Argentine] ; George Tomlinson [Pays-Bas] ; Tari Turner [Pays-Bas] ; Per O. Vandvik [Norvège] ; Robin Wm Vernooij [Équateur, Royaume-Uni] ; Andrés Viteri-García [États-Unis, Canada] ; Ying Wang [Argentine] ; Liang Yao [Argentine] ; Zhikang Ye [Argentine] ; Gordon H. Guyatt [Argentine, Corée du Sud] ; Romina Brignardello-Petersen [Argentine] ; Anila Qasim [Canada] ; Juan Pablo Diaz Martinez [Canada] ; Ellen Cusano [Canada]Drug treatments for covid-19: living systematic review and network meta-analysis.
001567 (2020) M. Million [France] ; P. Gautret [France] ; P. Colson [France] ; Y. Roussel [France] ; G. Dubourg [France] ; E. Chabriere [France] ; S. Honore [France] ; J-M Rolain [France] ; F. Fenollar [France] ; P-E Fournier [France] ; J-C Lagier [France] ; P. Parola [France] ; P. Brouqui [France] ; D. Raoult [France]Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world.
001583 (2020) Pablo Guisado-Vasco [Espagne] ; Sofia Valderas-Ortega [Espagne] ; Maria Maravillas Carral N-González [Espagne] ; Ana Roda-Santacruz [Espagne] ; Lucia González-Cortijo [Espagne] ; Gabriel Sotres-Fernández [Espagne] ; Eva María Martí-Ballesteros [Espagne] ; José Manuel Luque-Pinilla [Espagne] ; Elena Almagro-Casado [Espagne] ; Félix J. La Coma-Lanuza [Espagne] ; Ruth Barrena-Puertas [Espagne] ; Esteban Javier Malo-Benages [Espagne] ; María José Monforte-G Mez [Espagne] ; Rocío Diez-Munar [Espagne] ; Esther Merino-Lanza [Espagne] ; Lorena Comeche-Casanova [Espagne] ; Margarita Remirez-De-Esparza-Otero [Espagne] ; María Correyero-Plaza [Espagne] ; Manuel Recio-Rodríguez [Espagne] ; Margarita Rodríguez-L Pez [Espagne] ; María Dolores Sánchez-Manzano [Espagne] ; Cristina Andreu-Vázquez [Espagne] ; Israel John Thuissard-Vasallo [Espagne] ; José María Echave-Sustaeta María-Tomé [Espagne] ; Daniel Carnevali-Ruiz [Espagne]Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort).
001604 (2020) Michael Takla [Royaume-Uni] ; Kamalan Jeevaratnam [Royaume-Uni]Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
001629 (2020) Arunmozhimaran Elavarasi [Inde] ; Manya Prasad [Inde] ; Tulika Seth [Inde] ; Ranjit Kumar Sahoo [Inde] ; Karan Madan [Inde] ; Neeraj Nischal [Inde] ; Manish Soneja [Inde] ; Atul Sharma [Inde] ; Subir Kumar Maulik [Inde] ; Shalimar [Inde] ; Pramod Garg [Inde]Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
001958 (2020) Melanie A. Hundt [États-Unis] ; Yanhong Deng [États-Unis] ; Maria M. Ciarleglio [États-Unis] ; Michael H. Nathanson [États-Unis] ; Joseph K. Lim [États-Unis]Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
001961 (2020) Vaishali M. Patil [Inde] ; Shipra Singhal [Inde] ; Neeraj Masand [Inde]A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.
001964 (2020) Ramy Mohamed Ghazy [Égypte] ; Abdallah Almaghraby [Égypte] ; Ramy Shaaban [États-Unis] ; Ahmed Kamal [Égypte] ; Hatem Beshir [Égypte] ; Amr Moursi [Royaume-Uni] ; Ahmed Ramadan [Égypte] ; Sarah Hamed N. Taha [Égypte]A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.
000002 (2021) Fabricio Souza Neves [Brésil]Correlation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis.
000046 (2021) Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil]Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
000048 (2021) Samah Mohamad Lotfy [Égypte] ; Ahmad Abbas [Égypte] ; Waheed Shouman [Égypte]Use of Hydroxychloroquine in Patients with COVID-19: A Retrospective Observational Study.
000091 (2021) Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran]The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
000097 (2021) Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis]The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin.
000098 (2021) Antonio Desai [Italie] ; Giuseppe Caltagirone [Italie] ; Sharon Sari [Italie] ; Daria Pocaterra [Italie] ; Maria Kogan [Italie] ; Elena Azzolini [Italie] ; Victor Savevski [Italie] ; Filippo Martinelli-Boneschi [Italie] ; Antonio Voza [Italie] ; On Behalf Of The Humanitas Covid-Task Force [Italie]The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults.
000104 (2021) Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban]The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
000152 (2021) Inés Jiménez-Lozano [Espagne] ; José Manuel Caro-Teller [Espagne] ; Nuria Fernández-Hidalgo [Espagne] ; Marta Miarons [Espagne] ; Marie Antoinette Frick [Espagne] ; Emma Batllori Badia [Espagne] ; Berta Serrano [Espagne] ; Carlos Javier Parramon-Teixid [Espagne] ; Fátima Camba-Longueira [Espagne] ; Maria Teresa Moral-Pumarega [Espagne] ; Rafael San Juan-Garrido [Espagne] ; Maria Josep Caba As Poy [Espagne] ; Anna Suy [Espagne] ; Maria Queralt Gorgas Torner [Espagne]Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.
000158 (2021) Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte]Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
000159 (2021) Masoud Solaymani-Dodaran [Iran] ; Mostafa Ghanei [Iran] ; Mehdi Bagheri [Iran] ; Ali Qazvini [Iran] ; Ensieh Vahedi [Iran] ; Seyed Hassan Saadat [Iran] ; Seyed Amin Setarehdan [Iran] ; Akram Ansarifar [Iran] ; Hossein Biganeh [Iran] ; Arash Mohazzab [Iran] ; Davood Khalili [Iran] ; Amir Hosein Ghazale [Iran] ; Mohammad Reza Heidari [Iran] ; Ali Taheri [Iran] ; Maliheh Khoramdad [Iran] ; Mohammad Mahdi Asadi [Iran] ; Masoud Nazemieh [Iran] ; Mojtaba Varshochi [Iran] ; Samaneh Abbasian [Iran] ; Ali Bakhtiari [Iran] ; Reza Mosaed [Iran] ; Seyyed-Javad Hosseini-Shokouh [Iran] ; Masoume Shahrokhi [Iran] ; Zeynab Yassin [Iran] ; Mohammad Ali Zohal [Iran] ; Maryam Qaraati [Iran] ; Nafiseh Rastgoo [Iran] ; Ramin Sami [Iran] ; Mohammad Javad Eslami [Iran] ; Akram Asghari [Iran] ; Mansoor Namazi [Iran] ; Shadi Ziaie [Iran] ; Raana Jafari-Moghaddam [Iran] ; Saeid Kalantari [Iran] ; Mohammad Memarian [Iran] ; Javad Khodadadi [Iran] ; Mohammad Hossein Afshari [Iran] ; Mansooreh Momen-Heravi [Iran] ; Niusha Behzadseresht [Iran] ; Ahmad Reza Mobayen [Iran] ; Abolfazl Mozafari [Iran] ; Fatemeh Movasaghi [Iran] ; Maryam Haddadzadeh Shoushtari [Iran] ; Javad Moazen [Iran]Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.
000162 (2021) Subhrojyoti Bhowmick [Inde] ; Amit Dang [Inde] ; B N Vallish [Inde] ; Sumit Dang [États-Unis]Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review.
000213 (2021) Nicolas Dauby [Belgique] ; Joris Hautekiet [Belgique] ; Lucy Catteau [Belgique] ; Marion Montourcy [Belgique] ; Dominique Van Beckhoven [Belgique] ; Emmanuel Bottieau [Belgique] ; Els Goetghebeur [Belgique]Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'".
000215 (2021) Alexandre O. Gérard [France] ; Audrey Laurain [France] ; Audrey Fresse [France] ; Nadège Parassol [France] ; Marine Muzzone [France] ; Fanny Rocher [France] ; Vincent L M. Esnault [France] ; Milou-Daniel Drici [France]Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.
000228 (2021) Didier Raoult [France]Rational for meta-analysis and randomized treatment: the COVID-19 example.
000257 (2021) Daniel Sammartino [États-Unis] ; Farrukh Jafri [États-Unis] ; Brennan Cook [États-Unis] ; Lisa La [États-Unis] ; Hyemin Kim [États-Unis] ; John Cardasis [États-Unis] ; Joshua Raff [États-Unis]Predictors for inpatient mortality during the first wave of the SARS-CoV-2 pandemic: A retrospective analysis.
000276 (2021) Nida Bokharee [Pakistan] ; Yusra Habib Khan ; Aisha Khokhar [Pakistan] ; Tauqeer Hussain Mallhi ; Nasser Hadal Alotaibi ; Maria Rasheed [Pakistan]Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
000284 (2021) Prof Imad M. Tleyjeh [Arabie saoudite] ; Haytham Tlayjeh [Arabie saoudite]Perceived efficacy of hydroxychloroquine in observational studies: Results of the confounding effect of "goals of care".
000322 (2021) Cathrine Axfors [États-Unis, Suède] ; Andreas M. Schmitt [Suisse] ; Perrine Janiaud [Suisse] ; Janneke Van'T Hooft [États-Unis, Pays-Bas] ; Sherief Abd-Elsalam [Égypte] ; Ehab F. Abdo [Égypte] ; Benjamin S. Abella [États-Unis] ; Javed Akram [Pakistan] ; Ravi K. Amaravadi [États-Unis] ; Derek C. Angus [États-Unis] ; Yaseen M. Arabi [Arabie saoudite] ; Shehnoor Azhar [Pakistan] ; Lindsey R. Baden [États-Unis] ; Arthur W. Baker [États-Unis] ; Leila Belkhir [Belgique] ; Thomas Benfield [Danemark] ; Marvin A H. Berrevoets [Pays-Bas] ; Cheng-Pin Chen [Taïwan] ; Tsung-Chia Chen [Taïwan] ; Shu-Hsing Cheng [Taïwan] ; Chien-Yu Cheng [Taïwan] ; Wei-Sheng Chung [Taïwan] ; Yehuda Z. Cohen [États-Unis] ; Lisa N. Cowan [États-Unis] ; Olav Dalgard [Norvège] ; Fernando F. De Almeida E Val [Brésil] ; Marcus V G. De Lacerda [Brésil] ; Gisely C. De Melo [Brésil] ; Lennie Derde [Pays-Bas] ; Vincent Dubee [France] ; Anissa Elfakir [France] ; Anthony C. Gordon [Royaume-Uni] ; Carmen M. Hernandez-Cardenas [Mexique] ; Thomas Hills [Nouvelle-Zélande] ; Andy I M. Hoepelman [Pays-Bas] ; Yi-Wen Huang [Taïwan] ; Bruno Igau [États-Unis] ; Ronghua Jin [République populaire de Chine] ; Felipe Jurado-Camacho [Mexique] ; Khalid S. Khan [Espagne] ; Peter G. Kremsner [Allemagne, Gabon] ; Benno Kreuels [Allemagne] ; Cheng-Yu Kuo [Taïwan] ; Thuy Le [États-Unis] ; Yi-Chun Lin [Taïwan] ; Wu-Pu Lin [Taïwan] ; Tse-Hung Lin [Taïwan] ; Magnus Nakrem Lyngbakken [Norvège] ; Colin Mcarthur [Nouvelle-Zélande, Australie] ; Bryan J. Mcverry [États-Unis] ; Patricia Meza-Meneses [Mexique] ; Wuelton M. Monteiro [Brésil] ; Susan C. Morpeth [Nouvelle-Zélande] ; Ahmad Mourad [États-Unis] ; Mark J. Mulligan [États-Unis] ; Srinivas Murthy [Canada] ; Susanna Naggie [États-Unis] ; Shanti Narayanasamy [États-Unis] ; Alistair Nichol [Australie, Irlande (pays)] ; Lewis A. Novack [États-Unis] ; Sean M. O'Brien [États-Unis] ; Nwora Lance Okeke [États-Unis] ; Léna Perez [France] ; Rogelio Perez-Padilla [Mexique] ; Laurent Perrin [France] ; Arantxa Remigio-Luna [Mexique] ; Norma E. Rivera-Martinez [Mexique] ; Frank W. Rockhold [États-Unis] ; Sebastian Rodriguez-Llamazares [Mexique] ; Robert Rolfe [États-Unis] ; Rossana Rosa [États-Unis] ; Helge R Sj [Norvège] ; Vanderson S. Sampaio [Brésil] ; Todd B. Seto [États-Unis] ; Muhammad Shahzad [Pakistan] ; Shaimaa Soliman [Égypte] ; Jason E. Stout [États-Unis] ; Ireri Thirion-Romero [Mexique] ; Andrea B. Troxel [États-Unis] ; Ting-Yu Tseng [Taïwan] ; Nicholas A. Turner [États-Unis] ; Robert J. Ulrich [États-Unis] ; Stephen R. Walsh [États-Unis] ; Steve A. Webb [Australie] ; Jesper M. Weehuizen [Pays-Bas] ; Maria Velinova [Pays-Bas] ; Hon-Lai Wong [Taïwan] ; Rebekah Wrenn [États-Unis] ; Fernando G. Zampieri [Brésil] ; Wu Zhong [République populaire de Chine] ; David Moher [Canada] ; Steven N. Goodman [États-Unis] ; John P A. Ioannidis [États-Unis, Allemagne] ; Lars G. Hemkens [États-Unis, Suisse, Allemagne]Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
000368 (2021) Sophie Juul [Danemark] ; Emil Eik Nielsen [Danemark] ; Joshua Feinberg [Danemark] ; Faiza Siddiqui [Danemark] ; Caroline Kamp J Rgensen [Danemark] ; Emily Barot [Danemark] ; Johan Holgersson [Suède] ; Niklas Nielsen [Suède] ; Peter Bentzer [Suède] ; Areti Angeliki Veroniki [Grèce, Canada] ; Lehana Thabane [Canada] ; Fanlong Bu [République populaire de Chine] ; Sarah Klingenberg [Danemark] ; Christian Gluud [Danemark] ; Janus Christian Jakobsen [Danemark]Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
000483 (2021) Jesús Arturo Ruíz-Qui Onez [Mexique] ; Crystell Guadalupe Guzmán-Priego [Mexique] ; Germán Alberto Nolasco-Rosales [Mexique] ; Carlos Alfonso Tovilla-Zarate [Mexique] ; Oscar Israel Flores-Barrientos [Mexique] ; Víctor Narváez-Osorio [Mexique] ; Guadalupe Del Carmen Baeza-Flores [Mexique] ; Thelma Beatriz Gonzalez-Castro [Mexique] ; Carlos Ram N L Pez-Brito [Mexique] ; Carlos Alberto Denis-García [Mexique] ; Agustín Pérez-García [Mexique] ; Isela Esther Juárez-Rojop [Mexique]Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
000503 (2021) Qiuyu Li [République populaire de Chine] ; Cheng Cui [République populaire de Chine] ; Fei Xu [République populaire de Chine] ; Jianping Zhao [République populaire de Chine] ; Nan Li [République populaire de Chine] ; Haichao Li [République populaire de Chine] ; Tianbing Wang [République populaire de Chine] ; Hua Zhang [République populaire de Chine] ; Na Liu [République populaire de Chine] ; Yudong Wei [République populaire de Chine] ; Xiaoye Niu [République populaire de Chine] ; Yan Xu [République populaire de Chine] ; Jianping Dong [République populaire de Chine] ; Xueting Yao [République populaire de Chine] ; Xiaohong Wang [République populaire de Chine] ; Yahong Chen [République populaire de Chine] ; Haiyan Li [République populaire de Chine] ; Chunli Song [République populaire de Chine] ; Jie Qiao [République populaire de Chine] ; Dongyang Liu [République populaire de Chine] ; Ning Shen [République populaire de Chine]Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.
000521 (2021) Daniela R. Junqueira [Canada] ; Brian H. Rowe [Canada]Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.
000524 (2021) Amirreza Roostaei Firozabad [Iran] ; Zohreh Akhoundi Meybodi [Iran] ; Seyed Ruhollah Mousavinasab [Iran] ; Adeleh Sahebnasagh [Iran] ; Mohsen Gholinataj Jelodar [Iran] ; Iman Karimzadeh [Iran] ; Solomon Habtemariam [Royaume-Uni] ; Fatemeh Saghafi [Iran]Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial.
000525 (2021) Benjamin S. Abella [États-Unis] ; Eliana L. Jolkovsky [États-Unis] ; Barbara T. Biney [États-Unis] ; Julie E. Uspal [États-Unis] ; Matthew C. Hyman [États-Unis] ; Ian Frank [États-Unis] ; Scott E. Hensley [États-Unis] ; Saar Gill [États-Unis] ; Dan T. Vogl [États-Unis] ; Ivan Maillard [États-Unis] ; Daria V. Babushok [États-Unis] ; Alexander C. Huang [États-Unis] ; Sunita D. Nasta [États-Unis] ; Jennifer C. Walsh [États-Unis] ; E Paul Wiletyo [États-Unis] ; Phyllis A. Gimotty [États-Unis] ; Michael C. Milone [États-Unis] ; Ravi K. Amaravadi [États-Unis]Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
000541 (2021) Matthieu Million [France] ; Yanis Roussel [France] ; Philippe Gautret [France] ; Didier Raoult [France]Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
000548 (2021) Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie]Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study.
000549 (2021) Wei Xu [République populaire de Chine] ; Chenlu Huang [République populaire de Chine] ; Ling Fei [République populaire de Chine] ; Qiang Li [République populaire de Chine] ; Liang Chen [République populaire de Chine]Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.
000615 (2021) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Stéphane Honoré [France] ; Van Thuan Hoang [Viêt Nam] ; Didier Raoult [France]Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
000624 (2021) Saleh Alghamdi [Arabie saoudite] ; Bassant Barakat [Arabie saoudite] ; Ilhem Berrou [Royaume-Uni] ; Abdulhakim Alzahrani [Arabie saoudite] ; Abdul Haseeb [Arabie saoudite] ; Mohamed Anwar Hammad [Arabie saoudite] ; Sirajudheen Anwar [Arabie saoudite] ; Abdulmajeed Abdulghani A. Sindi [Arabie saoudite] ; Hussain A. Almasmoum [Arabie saoudite] ; Mohammad Albanghali [Arabie saoudite]Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia.
000630 (2021) Lauren K. Rangel [États-Unis] ; Payal Shah [États-Unis] ; Kristen Lo Sicco [États-Unis] ; Avrom S. Caplan [États-Unis] ; Alisa Femia [États-Unis]Chronic hydroxychloroquine therapy and COVID-19 outcomes: A retrospective case-control analysis.
000710 (2021) Jose Luis Rodriguez-Garcia ; Gines Sanchez-Nievas ; Juan Arevalo-Serrano ; Cristina Garcia-Gomez ; Jose Maria Jimenez-Vizuete ; Elisa Martinez-Alfaro [Espagne]Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
000717 (2021) Cathrine Axfors [États-Unis, Suède] ; Andreas M. Schmitt [Suisse] ; Perrine Janiaud [Suisse] ; Janneke Van'T Hooft [États-Unis, Pays-Bas] ; Sherief Abd-Elsalam [Égypte] ; Ehab F. Abdo [Égypte] ; Benjamin S. Abella [États-Unis] ; Javed Akram [Pakistan] ; Ravi K. Amaravadi [États-Unis] ; Derek C. Angus [États-Unis] ; Yaseen M. Arabi [Arabie saoudite] ; Shehnoor Azhar [Pakistan] ; Lindsey R. Baden [États-Unis] ; Arthur W. Baker [États-Unis] ; Leila Belkhir [Belgique] ; Thomas Benfield [Danemark] ; Marvin A H. Berrevoets [Pays-Bas] ; Cheng-Pin Chen [Taïwan] ; Tsung-Chia Chen [Taïwan] ; Shu-Hsing Cheng [Taïwan] ; Chien-Yu Cheng [Taïwan] ; Wei-Sheng Chung [Taïwan] ; Yehuda Z. Cohen [États-Unis] ; Lisa N. Cowan [États-Unis] ; Olav Dalgard [Norvège] ; Fernando F. De Almeida E Val [Brésil] ; Marcus V G. De Lacerda [Brésil] ; Gisely C. De Melo [Brésil] ; Lennie Derde [Pays-Bas] ; Vincent Dubee [France] ; Anissa Elfakir [France] ; Anthony C. Gordon [Royaume-Uni] ; Carmen M. Hernandez-Cardenas [Mexique] ; Thomas Hills [Nouvelle-Zélande] ; Andy I M. Hoepelman [Pays-Bas] ; Yi-Wen Huang [Taïwan] ; Bruno Igau [États-Unis] ; Ronghua Jin [République populaire de Chine] ; Felipe Jurado-Camacho [Mexique] ; Khalid S. Khan [Espagne] ; Peter G. Kremsner [Allemagne, Gabon] ; Benno Kreuels [Allemagne] ; Cheng-Yu Kuo [Taïwan] ; Thuy Le [États-Unis] ; Yi-Chun Lin [Taïwan] ; Wu-Pu Lin [Taïwan] ; Tse-Hung Lin [Taïwan] ; Magnus Nakrem Lyngbakken [Norvège] ; Colin Mcarthur [Nouvelle-Zélande, Australie] ; Bryan J. Mcverry [États-Unis] ; Patricia Meza-Meneses [Mexique] ; Wuelton M. Monteiro [Brésil] ; Susan C. Morpeth [Nouvelle-Zélande] ; Ahmad Mourad [États-Unis] ; Mark J. Mulligan [États-Unis] ; Srinivas Murthy [Canada] ; Susanna Naggie [États-Unis] ; Shanti Narayanasamy [États-Unis] ; Alistair Nichol [Australie, Irlande (pays)] ; Lewis A. Novack [États-Unis] ; Sean M. O'Brien [États-Unis] ; Nwora Lance Okeke [États-Unis] ; Léna Perez [France] ; Rogelio Perez-Padilla [Mexique] ; Laurent Perrin [France] ; Arantxa Remigio-Luna [Mexique] ; Norma E. Rivera-Martinez [Mexique] ; Frank W. Rockhold [États-Unis] ; Sebastian Rodriguez-Llamazares [Mexique] ; Robert Rolfe [États-Unis] ; Rossana Rosa [États-Unis] ; Helge R Sj [Norvège] ; Vanderson S. Sampaio [Brésil] ; Todd B. Seto [États-Unis] ; Muhammad Shahzad [Pakistan] ; Shaimaa Soliman [Égypte] ; Jason E. Stout [États-Unis] ; Ireri Thirion-Romero [Mexique] ; Andrea B. Troxel [États-Unis] ; Ting-Yu Tseng [Taïwan] ; Nicholas A. Turner [États-Unis] ; Robert J. Ulrich [États-Unis] ; Stephen R. Walsh [États-Unis] ; Steve A. Webb [Australie] ; Jesper M. Weehuizen [Pays-Bas] ; Maria Velinova [Pays-Bas] ; Hon-Lai Wong [Taïwan] ; Rebekah Wrenn [États-Unis] ; Fernando G. Zampieri [Brésil] ; Wu Zhong [République populaire de Chine] ; David Moher [Canada] ; Steven N. Goodman [États-Unis] ; John P A. Ioannidis [États-Unis, Allemagne] ; Lars G. Hemkens [États-Unis, Suisse, Allemagne]Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
000739 (2021) Stefano Celotto [Italie] ; Nicola Veronese [Italie] ; Mario Barbagallo [Italie] ; Francesca Ometto [Italie] ; Lee Smith [Royaume-Uni] ; Shahina Pardhan [Royaume-Uni] ; Yvonne Barnett [Royaume-Uni] ; Petre Cristian Ilie [Royaume-Uni] ; P Nar Soysal [Turquie] ; Erik Lagolio [Italie] ; Peter Konstantin Kurotschka [Italie] ; Roberto Tonelli [Italie] ; Jacopo Demurtas [Italie]An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy.
000782 (2021) Purwati [Indonésie] ; Budiono [Indonésie] ; Brian Eka Rachman [Indonésie] ; Yulistiani [Indonésie] ; Andang Miatmoko [Indonésie] ; Nasronudin [Indonésie] ; Soroy Lardo [Indonésie] ; Yongki Iswandi Purnama [Indonésie] ; Mafidhatul Laely [Indonésie] ; Ike Rochmad [Indonésie] ; Taufik Ismail [Indonésie] ; Sri Wulandari [Indonésie] ; Dwi Setyawan [Indonésie] ; Alfian Nur Rosyid [Indonésie] ; Herley Windo Setiawan [Indonésie] ; Prastuti Asta Wulaningrum [Indonésie] ; Tri Pudy Asmarawati [Indonésie] ; Erika Marfiani [Indonésie] ; Shinta Karina Yuniati [Indonésie] ; Muhammad Rabiul Fuadi [Indonésie] ; Pepy Dwi Endraswari [Indonésie] ; Purwaningsih [Indonésie] ; Eryk Hendrianto [Indonésie] ; Deya Karsari [Indonésie] ; Aristika Dinaryanti [Indonésie] ; Nora Ertanti [Indonésie] ; Igo Syaiful Ihsan [Indonésie] ; Disca Sandyakala Purnama [Indonésie] ; Yuni Indrayani [Indonésie]A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections.

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021